Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure
- PMID: 2332562
- DOI: 10.1016/0091-6749(90)90064-b
Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure
Erratum in
- J Allergy Clin Immunol 1991 Jan;87 (1 Pt 1):17
Abstract
This study examined plasma- and eosinophil-derived products in nasal lavage fluids obtained from patients with hay fever during natural allergen exposure. Nine patients with strictly seasonal allergic rhinitis and five normal, nonallergic subjects (control group) were studied. Nasal lavages were performed twice weekly, starting 1 week before the expected birch-pollen season and continuing for 6 weeks, thereby covering the entire birch-pollen season. Nasal symptoms and pollen counts were recorded daily. The lavage fluid was analyzed for it content of albumin, bradykinins, and eosinophil cationic protein (ECP). During the pollen season, each of these solutes was significantly increased in the nasal lavage fluid from the allergic patients (p less than 0.05) but not from the control subjects. Albumin, bradykinins, and ECP generally correlated better between themselves than with symptoms and pollen counts. We conclude that natural exposure to allergens induces plasma exudation and increased levels of ECP on the human nasal mucosa.
Similar articles
-
Alpha2-macroglobulin and eosinophil cationic protein in the allergic airway mucosa in seasonal allergic rhinitis.Eur Respir J. 1999 Mar;13(3):633-7. doi: 10.1183/09031936.99.13363399. Eur Respir J. 1999. PMID: 10232439 Clinical Trial.
-
Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis.J Allergy Clin Immunol. 1995 Nov;96(5 Pt 1):669-76. doi: 10.1016/s0091-6749(95)70266-0. J Allergy Clin Immunol. 1995. PMID: 7499684 Clinical Trial.
-
Glucocorticoid-induced attenuation of mucosal exudation of fibrinogen and bradykinins in seasonal allergic rhinitis.Allergy. 1994 Mar;49(3):177-83. doi: 10.1111/j.1398-9995.1994.tb00822.x. Allergy. 1994. PMID: 8198250 Clinical Trial.
-
Steroid-sensitive indices of airway inflammation in children with seasonal allergic rhinitis.Pediatr Allergy Immunol. 2003 Feb;14(1):60-5. doi: 10.1034/j.1399-3038.2003.02102.x. Pediatr Allergy Immunol. 2003. PMID: 12603713 Clinical Trial.
-
Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment.Clin Exp Allergy. 2001 Aug;31(8):1321-7. doi: 10.1046/j.1365-2222.2001.01029.x. Clin Exp Allergy. 2001. PMID: 11529904 Clinical Trial.
Cited by
-
Effects of intranasal TNFalpha on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis.Respir Res. 2008 Jan 30;9(1):15. doi: 10.1186/1465-9921-9-15. Respir Res. 2008. PMID: 18234086 Free PMC article. Clinical Trial.
-
Nasal mucus proteome and its involvement in allergic rhinitis.Expert Rev Proteomics. 2020 Mar;17(3):191-199. doi: 10.1080/14789450.2020.1748502. Epub 2020 Apr 8. Expert Rev Proteomics. 2020. PMID: 32266843 Free PMC article.
-
The kinin system in rhinitis and asthma.Clin Rev Allergy Immunol. 1998 Winter;16(4):351-64. doi: 10.1007/BF02737656. Clin Rev Allergy Immunol. 1998. PMID: 9926285 Review.
-
The use of the nose to study the inflammatory response of the respiratory tract.Thorax. 1992 Dec;47(12):993-1000. doi: 10.1136/thx.47.12.993. Thorax. 1992. PMID: 1494783 Free PMC article. No abstract available.
-
Hyperresponsiveness in the human nasal airway: new targets for the treatment of allergic airway disease.Mediators Inflamm. 1999;8(3):133-46. doi: 10.1080/09629359990469. Mediators Inflamm. 1999. PMID: 10704051 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical